rawfin.tv
Coeptis Therapeutics Merger Listing Approved by Nasdaq
MarketsstocksAI Generated

Coeptis Therapeutics Merger Listing Approved by Nasdaq

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Coeptis Therapeutics Holdings has announced that Nasdaq has approved the listing of its common stock following the merger with Z Squared. This approval paves the way for the combined entity to trade on the major exchange.

COEPMergerNasdaq ListingBiotech Sector

Related Articles

Ambarella Gains as Nvidia Emerges as Potential Third Bidder

Ambarella Gains as Nvidia Emerges as Potential Third Bidder

stocks
SpaceX and Tesla Boards Review Potential $3.5 Trillion Merger

SpaceX and Tesla Boards Review Potential $3.5 Trillion Merger

stocks
Elon Musk Explores Merger Between SpaceX and Tesla

Elon Musk Explores Merger Between SpaceX and Tesla

stocks
Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks